Products
Renal Drug Dosing for the Nephrology APRN and RN
May 1, 2021 10:00pm ‐ May 1, 2021 11:30pm
Patients have varying degrees of kidney disease and therefore need varying medication dosage adjustments. This presentation discusses how to distinguish renal dosing adjustments for antihypertensives, diabetic medications, and antimicrobials among others. A highlight for nephrology APs are reminders for effective renal drug dosing.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will have increased knowledge and ability to provide safe medication dosages to patients in varying stages of CKD.
Speaker(s):
- Leah Foster Smith, MSN, APRN, FNP-BC, CNN-NP, FNKF, Director of Advanced Practice Providers, Metrolina Nephrology Associates
Opening Ceremonies/President's Address /// Navigating the New Normal with I.D.E.A.S. (Inclusion, Data, Equity, Accountability, and Systems Change)
May 2, 2021 10:00am ‐ May 2, 2021 11:30am
Leaders at all levels are responsible for fostering teamwork and reaching “across the aisle” to promote inclusion and unity. We, as nurses, need to consider our roles in fostering a culture that is diverse and inclusive of other people, other ideas, and other ways of doing things. This session provides insights and strategies that we can all use to build our own leadership practices.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
Sponsored by AstraZeneca
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to promote inclusion, equity, and accountability to enable systems change in both formal and informal leadership positions.
Speaker(s):
- G. Rumay Alexander, EdD, RN, FAAN, Professor, University of North Carolina, Chapel Hill
The Nephrology Nurse's Role in Safe Opioid Prescription/Practices
May 2, 2021 11:45am ‐ May 2, 2021 12:45pm
Patients with chronic kidney disease are more likely to be prescribed opioids for pain associated with chronic conditions and comorbidities such as diabetes and hypertension. This session reviews the recommendations in the CDC Guideline for Prescribing Opioids for Chronic Pain, which will assist nephrology nurses to provide safer and more effective chronic pain treatment options, improve opioid prescribing practices, and reduce the number of patients with opioid use disorder, opioid misuse, or opioid-related harm.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to utilize the CDC Guideline for Prescribing Opioids for Chronic Pain appropriately.
Speaker(s):
- Loretta Jackson Brown, PhD, RN, CNN, Diversity, Equity, Belonging, Inclusion, and Accessibility Principle Advisor, Centers for Disease Control and Prevention
Urgent Start Peritoneal Dialysis (PD): What Nurses Need to Know
May 2, 2021 11:45am ‐ May 2, 2021 12:45pm
Urgent start PD is being used increasingly for individuals in need of acute dialysis. This session provides an overview of urgent start PD, including when it should be introduced, for which patients, nursing implications, patient care requirements, and the pathophysiologic changes associated with this treatment modality. The takeaway is an understanding of the differences among urgent start, early start, and traditional start PD.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Lucy B. Todd, MSN, ACNP-BC, CNN – Employed by Baxter Healthcare
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to describe the differences between urgent PD, urgent start, and traditional PD, along with indications and nursing implications for each treatment.
Speaker(s):
- Lucy Todd, MSN, ACNP-BC, CNN, Senior Principal Medical Liaison, Baxter Healthcare
The Nephrology Nurse's Role in Managing Hyperkalemia in Patients with CKD (Sponsored by Vifor Pharma)
May 2, 2021 1:00pm ‐ May 2, 2021 2:15pm
Nephrology nurses frequently care for patients with CKD who have side effects from hyperkalemia. This session discusses the challenges and a nephrology nurse’s role in planning care for these patients, including pharmacologic and non-pharmacologic measures.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
Supported through an educational grant from Vifor Pharma.
No other commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will state an increased ability to plan care for patients with CKD experiencing hyperkalemia.
Speaker(s):
- Mary Schira, PhD, APRN, ACNP-BC, Clinical Associate Professor; Student Success Faculty, University of Texas at Arlington
New Nurse Residency Programs
May 2, 2021 3:00pm ‐ May 2, 2021 4:00pm
What are nurse residency programs and why are they becoming increasingly important in today’s work environment? This session answers these questions and provides an overview of nurse residency programs, including benefits to specialty areas, costs, suggestions for marketing, and the necessary program evaluation process.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will describe an increased knowledge of, and support for, new nurse residency programs.
Speaker(s):
- Sharon Bragg, DNP, RN, CCRN, Assistant Nurse Manager, UVA Health
Liver Disease and Chronic Kidney Disease
May 2, 2021 3:00pm ‐ May 2, 2021 4:00pm
Liver disease is often noted in patients with chronic kidney disease (CKD). This session reviews risk factors and the development of liver failure in patients with CKD, as well as diagnostic evaluation and therapeutic management in outpatient and inpatient settings. The discussion also focuses on the challenges of managing advanced liver failure and advanced CKD.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to discuss the plan of care for patients with CKD who also have liver disease.
Speaker(s):
- Melissa Anderson, MD, Associate Professor, Indiana University
Telehealth: What You Need to Know
May 2, 2021 4:15pm ‐ May 2, 2021 5:15pm
During the pandemic, telehealth took a more prominent role in how people interacted with their healthcare providers. This session discusses ways to incorporate telehealth into your clinic using best practices and lessons learned from other facilities that have implemented telehealth. Tips on reimbursement and billing, as well as predictions about the future of telehealth are shared.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Michael A. Kraus, MD – Salary from Fresenius Kidney Care, Inc.
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to incorporate telehealth best practices into daily workflow.
Speaker(s):
- Michael A. Kraus, MD, Chief Medical Officer, Fresenius Kidney Care
My Neighbor Said I Needed These: The Promise of Herbals and Supplements
May 2, 2021 6:00pm ‐ May 2, 2021 7:00pm
Have you worked with a patient who stated, “My neighbor said I should take these supplements because they will make me better.” What was your response? This session addresses this scenario and provides tips for how nurses can handle conversations with patients about herbals and supplements and their potential impact on kidney health.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Kristin Larson, MSN, RN, AGNP-BC – Salary from United Health Group and Speaker’s Bureau for AstraZeneca
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will state an increased competence with their ability to talk with patients about herbals and supplements and the potential interaction with prescribed medications.
Speaker(s):
- Kristin Larson, MSN, RN, AGNP-BC, CN, House Calls Nurse Practitioner
Patient Activation and Self-Management for People with CKD and ESRD
May 2, 2021 6:00pm ‐ May 2, 2021 7:00pm
Patient activation – the willingness and ability of a person to manage their healthcare – provides nephrology nurses with a concept and measurement tool to classify people with kidney disease into various activation levels. Applying an individualized approach to patients based on their activation level may increase patients’ self-care and self-management of their disease process.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Paul Bennett, PhD, MHSM, RN, BN, GCertSc – Salary from Satellite Healthcare
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to utilize a patient activation system (when appropriate) to determine appropriate interventions and management.
Speaker(s):
- Paul N. Bennett, PhD, MHSM, RN, BN, GCertSc, Director of Research, Satellite Healthcare